Related Experiment Video
Updated: Apr 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
[Congestive heart failure in patients with chronic kidney disease]
Insights
Cardiovascular disorders are a leading cause of death in chronic renal failure (CRF) patients on dialysis. Managing heart failure in these patients involves standard therapies and dialysis techniques to control fluid overload.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Cardiovascular disorders cause 46-60% of deaths in advanced chronic renal failure (CRF) patients undergoing dialysis.
- Uremic cardiomyopathy, ischemic heart disease (IHD), and anemia are key contributors to congestive heart failure (CHF) in this population.
- Specific risk factors associated with kidney failure and dialysis exacerbate these cardiac issues.
Purpose of the Study:
- To review the pathophysiology, diagnosis, and management of cardiovascular disorders in patients with advanced chronic renal failure on dialysis.
- To highlight the challenges in diagnosing heart failure due to unreliable biohumoral markers in CRF patients.
- To discuss current therapeutic strategies, including dialysis-based fluid management and specific cardiac interventions.
Main Methods:
- Review of existing literature on cardiovascular complications in CRF patients.
- Analysis of diagnostic methods for congestive heart failure (CHF) in dialysis patients.
- Evaluation of therapeutic approaches, including pharmacological treatments and dialysis modalities.
Main Results:
- Congestive heart failure (CHF) is a common and serious complication in dialysis patients, driven by uremic cardiomyopathy, IHD, and anemia.
- Diagnosis relies on clinical assessment, ECG, echocardiography, and radiology, as biohumoral markers like BNP are less reliable.
- Fluid management through ultrafiltration during hemodialysis/hemodiafiltration and peritoneal dialysis is crucial for controlling hypervolemia.
Conclusions:
- Cardiovascular disease management in CRF patients requires a multi-faceted approach, integrating standard cardiac therapies with dialysis techniques.
- Revascularization procedures are beneficial for associated IHD, while cardiac resynchronization and defibrillator implantation may be considered in selected cases.
- Effective management of fluid balance is paramount in preventing and treating heart failure in patients with advanced chronic renal failure.
Abstract:
Cardiovascular disorders are the most frequent cause of death (46-60%) among patients with advanced chronic renal failure (CRF), and on dialysis treatment. Uremic cardiomyopathy is the basic pathophysiologic substrate, whereas ischemic heart disease (IHD) and anemia are the most important contributing factors. Associated with well-know risk factors and specific disorders for terminal kidney failure and dialysis, the aforementioned factors instigate congestive heart failure (CHF). Suspected CHF is based on the anamnesis, clinical examination and ECG, while it is confirmed and defined more precisely on the basis of echocardiography and radiology examination. Biohumoral data (BNP, NT-proBNP) are not sufficiently reliable because of specific volemic fluctuation and reduced natural clearance. Therapy approach is similar to the one for the general population: ACEI, ARBs, β-blockers, inotropic drugs and diuretics. Hypervolemia and most of the related symptoms can be kept under control effectively by the isolated or ultrafiltation, in conjunction with dialysis, during the standard bicarbonate hemodialysis or hemodiafiltration. In the same respect peritoneal dialysis is efficient for the control of hypervolemia symptoms, mainly during the first years of its application and in case of the lower NYHA class (II°/III°). In general, heart support therapy, surgical interventions of the myocardium and valve replacement are rarely used in patients on dialysis, whereas revascularization procedures are beneficial for associated IHD. In selected cases the application of cardiac resynchronization and/or implantation of a cardioverter defibrillator are advisable.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Diuretics
Chronic Kidney Disease III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction

